English
简体中文
Total: £ 56.28
Published Date: 2025-10-15 | Pages: 128 | Tables: 127 | Medical Care
The global Third-party Medical Central Sterile Supply Department market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
The third-party Medical Central Sterile Supply Department (CSSD) refers to independent sterilization service providers that are built and operated by specialized companies or influential medical institutions, without relying on hospital facilities. These centers are characterized by regionalization, centralization, and professionalization, offering high-quality, efficient sterilization services to healthcare institutions. By outsourcing sterilization, medical facilities can reduce capital investments, lower operational costs, and improve the quality and efficiency of sterilization, significantly reducing infection risks. This outsourcing model has become an essential solution for many healthcare institutions facing expansion demands and resource pressures, helping them meet modern medical requirements more effectively.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Third-party Medical Central Sterile Supply Department leading manufacturers including STERIS, Getinge, Sterigenics, Omnia Health, Laoken Medical, Aecssd Medical, Julikang, Steriguard Medical, Zhongjin Irradiation, Jul Union, etc., dominate supply; the top five capture approximately % of global revenue, with STERIS leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Third-party Medical Central Sterile Supply Department market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
STERIS
Getinge
Sterigenics
Omnia Health
Laoken Medical
Aecssd Medical
Julikang
Steriguard Medical
Zhongjin Irradiation
Jul Union
Segment by Type
Irradiation Sterilization
Ethylene Oxide (EO) Sterilization
Segment by Application
Hospital
Clinic
Medical Beauty Institution
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Third-party Medical Central Sterile Supply Department study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Third-party Medical Central Sterile Supply Department: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Third-party Medical Central Sterile Supply Department Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Irradiation Sterilization
1.2.3 Ethylene Oxide (EO) Sterilization
1.3 Market Segmentation by Application
1.3.1 Global Third-party Medical Central Sterile Supply Department Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Beauty Institution
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Third-party Medical Central Sterile Supply Department Revenue Estimates and Forecasts 2020-2031
2.2 Global Third-party Medical Central Sterile Supply Department Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Third-party Medical Central Sterile Supply Department Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Third-party Medical Central Sterile Supply Department Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Irradiation Sterilization Market Size by Players
3.3.2 Ethylene Oxide (EO) Sterilization Market Size by Players
3.4 Global Third-party Medical Central Sterile Supply Department Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Third-party Medical Central Sterile Supply Department Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Third-party Medical Central Sterile Supply Department Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Third-party Medical Central Sterile Supply Department Market Size by Type (2020-2031)
6.4 North America Third-party Medical Central Sterile Supply Department Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Third-party Medical Central Sterile Supply Department Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Third-party Medical Central Sterile Supply Department Market Size by Type (2020-2031)
7.4 Europe Third-party Medical Central Sterile Supply Department Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Third-party Medical Central Sterile Supply Department Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Third-party Medical Central Sterile Supply Department Market Size by Type (2020-2031)
8.4 Asia-Pacific Third-party Medical Central Sterile Supply Department Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Third-party Medical Central Sterile Supply Department Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Third-party Medical Central Sterile Supply Department Market Size by Type (2020-2031)
9.4 Central and South America Third-party Medical Central Sterile Supply Department Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Third-party Medical Central Sterile Supply Department Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Third-party Medical Central Sterile Supply Department Market Size by Type (2020-2031)
10.4 Middle East and Africa Third-party Medical Central Sterile Supply Department Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Third-party Medical Central Sterile Supply Department Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 STERIS
11.1.1 STERIS Corporation Information
11.1.2 STERIS Business Overview
11.1.3 STERIS Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.1.4 STERIS Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.1.5 STERIS Third-party Medical Central Sterile Supply Department Revenue by Product in 2024
11.1.6 STERIS Third-party Medical Central Sterile Supply Department Revenue by Application in 2024
11.1.7 STERIS Third-party Medical Central Sterile Supply Department Revenue by Geographic Area in 2024
11.1.8 STERIS Third-party Medical Central Sterile Supply Department SWOT Analysis
11.1.9 STERIS Recent Developments
11.2 Getinge
11.2.1 Getinge Corporation Information
11.2.2 Getinge Business Overview
11.2.3 Getinge Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.2.4 Getinge Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.2.5 Getinge Third-party Medical Central Sterile Supply Department Revenue by Product in 2024
11.2.6 Getinge Third-party Medical Central Sterile Supply Department Revenue by Application in 2024
11.2.7 Getinge Third-party Medical Central Sterile Supply Department Revenue by Geographic Area in 2024
11.2.8 Getinge Third-party Medical Central Sterile Supply Department SWOT Analysis
11.2.9 Getinge Recent Developments
11.3 Sterigenics
11.3.1 Sterigenics Corporation Information
11.3.2 Sterigenics Business Overview
11.3.3 Sterigenics Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.3.4 Sterigenics Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.3.5 Sterigenics Third-party Medical Central Sterile Supply Department Revenue by Product in 2024
11.3.6 Sterigenics Third-party Medical Central Sterile Supply Department Revenue by Application in 2024
11.3.7 Sterigenics Third-party Medical Central Sterile Supply Department Revenue by Geographic Area in 2024
11.3.8 Sterigenics Third-party Medical Central Sterile Supply Department SWOT Analysis
11.3.9 Sterigenics Recent Developments
11.4 Omnia Health
11.4.1 Omnia Health Corporation Information
11.4.2 Omnia Health Business Overview
11.4.3 Omnia Health Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.4.4 Omnia Health Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.4.5 Omnia Health Third-party Medical Central Sterile Supply Department Revenue by Product in 2024
11.4.6 Omnia Health Third-party Medical Central Sterile Supply Department Revenue by Application in 2024
11.4.7 Omnia Health Third-party Medical Central Sterile Supply Department Revenue by Geographic Area in 2024
11.4.8 Omnia Health Third-party Medical Central Sterile Supply Department SWOT Analysis
11.4.9 Omnia Health Recent Developments
11.5 Laoken Medical
11.5.1 Laoken Medical Corporation Information
11.5.2 Laoken Medical Business Overview
11.5.3 Laoken Medical Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.5.4 Laoken Medical Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.5.5 Laoken Medical Third-party Medical Central Sterile Supply Department Revenue by Product in 2024
11.5.6 Laoken Medical Third-party Medical Central Sterile Supply Department Revenue by Application in 2024
11.5.7 Laoken Medical Third-party Medical Central Sterile Supply Department Revenue by Geographic Area in 2024
11.5.8 Laoken Medical Third-party Medical Central Sterile Supply Department SWOT Analysis
11.5.9 Laoken Medical Recent Developments
11.6 Aecssd Medical
11.6.1 Aecssd Medical Corporation Information
11.6.2 Aecssd Medical Business Overview
11.6.3 Aecssd Medical Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.6.4 Aecssd Medical Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.6.5 Aecssd Medical Recent Developments
11.7 Julikang
11.7.1 Julikang Corporation Information
11.7.2 Julikang Business Overview
11.7.3 Julikang Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.7.4 Julikang Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.7.5 Julikang Recent Developments
11.8 Steriguard Medical
11.8.1 Steriguard Medical Corporation Information
11.8.2 Steriguard Medical Business Overview
11.8.3 Steriguard Medical Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.8.4 Steriguard Medical Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.8.5 Steriguard Medical Recent Developments
11.9 Zhongjin Irradiation
11.9.1 Zhongjin Irradiation Corporation Information
11.9.2 Zhongjin Irradiation Business Overview
11.9.3 Zhongjin Irradiation Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.9.4 Zhongjin Irradiation Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.9.5 Zhongjin Irradiation Recent Developments
11.10 Jul Union
11.10.1 Jul Union Corporation Information
11.10.2 Jul Union Business Overview
11.10.3 Jul Union Third-party Medical Central Sterile Supply Department Product Features and Attributes
11.10.4 Jul Union Third-party Medical Central Sterile Supply Department Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Third-party Medical Central Sterile Supply DepartmentIndustry Chain Analysis
12.1 Third-party Medical Central Sterile Supply Department Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Third-party Medical Central Sterile Supply Department Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Third-party Medical Central Sterile Supply Department Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Third-party Medical Central Sterile Supply Department Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Third-party Medical Central Sterile Supply Department Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Third-party Medical Central Sterile Supply Department Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Third-party Medical Central Sterile Supply Department Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Third-party Medical Central Sterile Supply Department Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Third-party Medical Central Sterile Supply Department Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Third-party Medical Central Sterile Supply Department Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Third-party Medical Central Sterile Supply Department by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third-party Medical Central Sterile Supply Department as of 2024)
Table 11. Global Third-party Medical Central Sterile Supply Department Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Third-party Medical Central Sterile Supply Department Companies Headquarters
Table 13. Global Third-party Medical Central Sterile Supply Department Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Third-party Medical Central Sterile Supply Department Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Third-party Medical Central Sterile Supply Department Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Third-party Medical Central Sterile Supply Department Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Third-party Medical Central Sterile Supply Department Revenue by Application (2026-2031) & (US$ Million)
Table 21. Third-party Medical Central Sterile Supply Department High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Third-party Medical Central Sterile Supply Department Growth Accelerators and Market Barriers
Table 25. North America Third-party Medical Central Sterile Supply Department Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Third-party Medical Central Sterile Supply Department Growth Accelerators and Market Barriers
Table 27. Europe Third-party Medical Central Sterile Supply Department Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Third-party Medical Central Sterile Supply Department Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Third-party Medical Central Sterile Supply Department Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Third-party Medical Central Sterile Supply Department Investment Opportunities and Key Challenges
Table 31. Central and South America Third-party Medical Central Sterile Supply Department Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Third-party Medical Central Sterile Supply Department Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Third-party Medical Central Sterile Supply Department Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. STERIS Corporation Information
Table 35. STERIS Description and Major Businesses
Table 36. STERIS Product Features and Attributes
Table 37. STERIS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. STERIS Revenue Proportion by Product in 2024
Table 39. STERIS Revenue Proportion by Application in 2024
Table 40. STERIS Revenue Proportion by Geographic Area in 2024
Table 41. STERIS Third-party Medical Central Sterile Supply Department SWOT Analysis
Table 42. STERIS Recent Developments
Table 43. Getinge Corporation Information
Table 44. Getinge Description and Major Businesses
Table 45. Getinge Product Features and Attributes
Table 46. Getinge Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Getinge Revenue Proportion by Product in 2024
Table 48. Getinge Revenue Proportion by Application in 2024
Table 49. Getinge Revenue Proportion by Geographic Area in 2024
Table 50. Getinge Third-party Medical Central Sterile Supply Department SWOT Analysis
Table 51. Getinge Recent Developments
Table 52. Sterigenics Corporation Information
Table 53. Sterigenics Description and Major Businesses
Table 54. Sterigenics Product Features and Attributes
Table 55. Sterigenics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Sterigenics Revenue Proportion by Product in 2024
Table 57. Sterigenics Revenue Proportion by Application in 2024
Table 58. Sterigenics Revenue Proportion by Geographic Area in 2024
Table 59. Sterigenics Third-party Medical Central Sterile Supply Department SWOT Analysis
Table 60. Sterigenics Recent Developments
Table 61. Omnia Health Corporation Information
Table 62. Omnia Health Description and Major Businesses
Table 63. Omnia Health Product Features and Attributes
Table 64. Omnia Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Omnia Health Revenue Proportion by Product in 2024
Table 66. Omnia Health Revenue Proportion by Application in 2024
Table 67. Omnia Health Revenue Proportion by Geographic Area in 2024
Table 68. Omnia Health Third-party Medical Central Sterile Supply Department SWOT Analysis
Table 69. Omnia Health Recent Developments
Table 70. Laoken Medical Corporation Information
Table 71. Laoken Medical Description and Major Businesses
Table 72. Laoken Medical Product Features and Attributes
Table 73. Laoken Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Laoken Medical Revenue Proportion by Product in 2024
Table 75. Laoken Medical Revenue Proportion by Application in 2024
Table 76. Laoken Medical Revenue Proportion by Geographic Area in 2024
Table 77. Laoken Medical Third-party Medical Central Sterile Supply Department SWOT Analysis
Table 78. Laoken Medical Recent Developments
Table 79. Aecssd Medical Corporation Information
Table 80. Aecssd Medical Description and Major Businesses
Table 81. Aecssd Medical Product Features and Attributes
Table 82. Aecssd Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Aecssd Medical Recent Developments
Table 84. Julikang Corporation Information
Table 85. Julikang Description and Major Businesses
Table 86. Julikang Product Features and Attributes
Table 87. Julikang Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Julikang Recent Developments
Table 89. Steriguard Medical Corporation Information
Table 90. Steriguard Medical Description and Major Businesses
Table 91. Steriguard Medical Product Features and Attributes
Table 92. Steriguard Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Steriguard Medical Recent Developments
Table 94. Zhongjin Irradiation Corporation Information
Table 95. Zhongjin Irradiation Description and Major Businesses
Table 96. Zhongjin Irradiation Product Features and Attributes
Table 97. Zhongjin Irradiation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Zhongjin Irradiation Recent Developments
Table 99. Jul Union Corporation Information
Table 100. Jul Union Description and Major Businesses
Table 101. Jul Union Product Features and Attributes
Table 102. Jul Union Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Jul Union Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Third-party Medical Central Sterile Supply Department Product Picture
Figure 2. Global Third-party Medical Central Sterile Supply Department Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Irradiation Sterilization Product Picture
Figure 4. Ethylene Oxide (EO) Sterilization Product Picture
Figure 5. Global Third-party Medical Central Sterile Supply Department Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Medical Beauty Institution
Figure 9. Other
Figure 10. Third-party Medical Central Sterile Supply Department Report Years Considered
Figure 11. Global Third-party Medical Central Sterile Supply Department Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 13. Global Third-party Medical Central Sterile Supply Department Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Third-party Medical Central Sterile Supply Department Revenue Market Share by Region (2020-2031)
Figure 15. Global Third-party Medical Central Sterile Supply Department Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Irradiation Sterilization Revenue Market Share by Player in 2024
Figure 18. Ethylene Oxide (EO) Sterilization Revenue Market Share by Player in 2024
Figure 19. Global Third-party Medical Central Sterile Supply Department Revenue Market Share by Type (2020-2031)
Figure 20. Global Third-party Medical Central Sterile Supply Department Revenue Market Share by Application (2020-2031)
Figure 21. North America Third-party Medical Central Sterile Supply Department Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Third-party Medical Central Sterile Supply Department Revenue (US$ Million) in 2024
Figure 23. North America Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Third-party Medical Central Sterile Supply Department Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Third-party Medical Central Sterile Supply Department Revenue (US$ Million) in 2024
Figure 30. Europe Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 33. France Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Third-party Medical Central Sterile Supply Department Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Third-party Medical Central Sterile Supply Department Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 45. India Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Third-party Medical Central Sterile Supply Department Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Third-party Medical Central Sterile Supply Department Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Third-party Medical Central Sterile Supply Department Revenue (US$ Million) in 2024
Figure 53. Central and South America Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Third-party Medical Central Sterile Supply Department Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Third-party Medical Central Sterile Supply Department Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Third-party Medical Central Sterile Supply Department Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Third-party Medical Central Sterile Supply Department Revenue (US$ Million) in 2024
Figure 59. South America Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Third-party Medical Central Sterile Supply Department Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Third-party Medical Central Sterile Supply Department Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Third-party Medical Central Sterile Supply Department Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Third-party Medical Central Sterile Supply Department Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Third-party Medical Central Sterile Supply Department Revenue (2020-2025) & (US$ Million)
Figure 65. Third-party Medical Central Sterile Supply Department Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
